Grants
Health Equity and the Cost of Novel Treatments for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed) (RFA-AG-24-050)
Sponsor
National Institute on Aging
Due Date
LOI due September 29, 2023. Application due October 31, 2023.